Prasugrel-Induced Thrombocytopenia After Percutaneous Coronary Intervention

Am J Ther. 2019 May/Jun;26(3):e425-e426. doi: 10.1097/MJT.0000000000000822.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Coronary Syndrome / diagnosis
  • Acute Coronary Syndrome / drug therapy
  • Acute Coronary Syndrome / etiology
  • Aged
  • Coronary Angiography
  • Coronary Artery Disease / surgery
  • Coronary Thrombosis / diagnosis*
  • Coronary Thrombosis / etiology
  • Coronary Thrombosis / prevention & control
  • Drug-Eluting Stents
  • Humans
  • Male
  • Percutaneous Coronary Intervention / adverse effects*
  • Platelet Aggregation Inhibitors / adverse effects*
  • Platelet Count
  • Prasugrel Hydrochloride / adverse effects*
  • Thrombocytopenia / blood
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / diagnosis

Substances

  • Platelet Aggregation Inhibitors
  • Prasugrel Hydrochloride